Temperature and SARS-COV-2 transmission:

Some seasonality expected for resp viruses, hard to say how much. England had unique circumstance Feb 7-13th.

- week long cold snap across country of similar magnitude
- no change in restrictions
- no increase in daily mobility

1/
Due to variables being reasonably controlled we can estimate how temperature may affect general transmission dynamics.

Note Seasonality: viruses transmit at ALL times of year but climate affects biology and behaviour which impacts on how much transmission occurs.

2/
Cases by specimen date in England showed a marked deceleration in the rate of decline the week after the cold period. From more than -5% per day to less than -2%.

(daily change adjusted for day of the week effect in testing)

3/
Those people testing positive on a given day didn't all catch SARS-COV-2 at the same time

Mean time from exposure to symptoms is 5.5 days + time for getting test (2days). There's a distribution (log-normal best fit) with slightly longer tail. ~8 days from infection to test.

4/
Daily growth rate can then be changed into R.

There's a high degree of correlation with temperature.

Pearson correlation coefficient 0.79

2.2% [1.7-2.6] increase in R per 1C decrease in temp

(humidity correlation coefficient separately 0.46)

5/
As an aside: changes in R affect time from exposure to test specimen. As R<1 weight is behind the right of the probability distribution (old exposures slightly dominant and R marginally too high by spec date). Further decline negligibly changes this until equilibrium.

6/
Anyways correlation ≠ causation. Considering other factors.

In Lockdown mobility increases 2.5% avg week on week despite no change in restrictions instead change in behaviour/adherence.

However that week was low/negative between Feb 9-13. Only time in any lockdown.

7/
Result of snow/ice conditions etc and people staying indoors at home.

Usual caveat applies that mobility!= transmission risk

Therefore expectation would be fall in R considering mobility alone.

8/
Also vaccination removes people from the susceptible population and proportionally reduces effective R.

Using compartmentalised mixing of over 70's and vulnerable groups with conservative 65% efficacy and 3 week till protection we see baseline R should have declined.

9/
Physical attendance in school ~18% nationally is unlikely to have contributed to the rising R in week 6 followed by rapid decline week 7 (half term). Effect on case rate was uniform across ages in both weeks, with no delay to infer secondary transmission via children.

10/
IF change in R with temperature is as indicated by this ecological study we can expect seasonality of 29% [22-35] from peak to trough in England over the year. R0 +/- 16%

Slightly higher than Imperial model (20% peak to trough)

11/
However scope of behavioural change was limited in the study period by lock down restrictions. eg indoor socialising with other households rather than outdoor etc.
Which may underestimate impact.

12/
Biological factors contributing to seasonality:

-virus stability
-humidity and temp affecting transmission dynamics
-mucociliary clearance
-epithelial integrity
-innate immune efficiency

13/

Nice review paper of physiology👇

annualreviews.org/doi/pdf/10.114…
In the context of B117 in England with year average R0=4

This would mean R 4.6 in winter and R 3.4 in summer.

Potential for year round exponential growth and epidemic outbreaks without either pre-existing immunity (vax or prior infxn) or social distancing restrictions.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Devan Sinha

Devan Sinha Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DevanSinha

31 Dec 20
The AZ/oxford vac shows high immunogenicity and efficacy when delayed to 12 weeks for 2nd dose. Ab titres highest for 12 weeks 👇

BUT the delay for Pfizer vac though potential large societal benefits is definitely a risk...

🧵 1/
1. Pfizer efficacy was only trialled at 21 days for 2nd dose. (cf AZ/Ox 4-26 weeks)

2. This can be estimated at ~80-90% for 10-22 days after 1st dose

2/

But Ab tires don't increase until 2nd dose for Pfizer, especially in the older age cohort who are the priority vaccine targets. How much protection are we giving them?👇

The 86% is a pooled estimate of all ages with younger population dominating.

3/
Read 8 tweets
30 Dec 20
Disentangling Astra/Oxford vaccine data (it's a messy trial/ data presentation):

Efficacy after 1st dose overall: 52.69% (95%CI 40.52-62.37)
108 v 227 cases/10k cohorts

Subgroup analysis from 3 weeks after 1st dose until 2nd dose or 12 weeks: 73.00% (48.79-85.76)
12 v 44/8k

1/
Overall vaccine efficacy with 2 completed doses: 70.42% (95%CI 58.84-80.63)
30 v 101 cases/5.8k cohorts

0 hospitalised and 0 severe disease in full vaccine cohort

For 1 dose subgroup only 2 hospitalisations (day 1 and 10 post vaccine when no immunity conferred), 0 severe

2/
The trial is limited by the variability in administration of the second dose between 4 to 26 weeks.

Higher antibody titres were seen when delaying 2nd dose to 12 weeks

Only 5.9% of trial were over 65, and they tended to be in the early 2nd dose category

3/
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!